Menstrual Cycle Premenstrual Disorders

Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome

Fathizadeh N, Ebrahimi E, Valiani M, Tavakoli N, Yar MH

Published December 2010 Iranian journal of nursing and midwifery research, 15(Suppl 1), 401-5
PMID 22069417 PMC PMC3208934

RRM Academy Synopsis

Magnesium plus vitamin B6 lowered PMS symptom scores most

A placebo-controlled trial in Iran found that magnesium plus vitamin B6 lowered premenstrual syndrome symptom scores more than magnesium alone or placebo. Researchers randomized 150 women into three groups of 50 and followed them for two menstrual cycles.

Key Findings

  • 150 women who met the American Psychiatry Association criteria for PMS were randomly assigned to three groups of 50: magnesium, magnesium plus vitamin B6, or placebo.
  • Completing the study were 38 women in the magnesium group, 41 in the magnesium plus vitamin B6 group, and 37 in the placebo group.
  • Mean PMS symptom scores did not differ between groups before treatment (p > 0.76) and differed significantly after treatment (p < 0.001).
  • Mean symptom scores decreased significantly in all three groups (p < 0.05), with the largest decrease in the magnesium plus vitamin B6 group and the smallest in the placebo group.
  • Magnesium plus vitamin B6 was more effective than magnesium and placebo in lowering the mean score of PMS symptoms (p < 0.05).

Interpretation

The study is a double-blinded placebo-controlled randomized trial. Participants were women aged 15 to 45 with regular cycles, no depression or anxiety, no acute or chronic disease, and no regular supplements or exercise. Women rated each symptom daily from zero to three. Treatment lasted two menstrual cycles. Scores also fell in the placebo group, and the authors note the placebo effect in PMS studies is considerable.

RRM Context

Restorative reproductive medicine treats cycle-linked symptoms at their source. Diagnosis here rested on two months of daily symptom records, the same daily observation that cycle charting builds. Nutrient supplementation leaves the menstrual cycle intact.

Abstract

Background

Since premenstrual syndrome (PMS) can cause suicide, dissociation of familial relationships, abnormalities in the daily work and inter-personal relationships in the patients, and bring about direct and indirect economic burden for the society, it is important to resolve the problems of the patients. The objective of the current study is to determine the effect of magnesium (Mg), combination of vitamin B6 and Mg, and the placebo on the severity of PMS in the patients affected by the disease referred to the health centers of Isfahan University of Medical Sciences during 2009-2010.

Methods

The participants were randomly assigned to two intervention groups and one control group. The study was carried out for four months in ten selected health centers in Isfahan. To confirm the PMS diagnosis in patients, they were asked to fill out the PMS daily symptom record form for two months and then, when the diagnosis was confirmed, the participants were randomly assigned to one of the three groups of the study (Mg, Mg plus vitamin B6, and placebo). Medical intervention was carried out in two menstrual cycles and the results of pre- and post-test were compared.

Results

After the intervention, the mean score of PMS significantly decreased in all the three groups (p < 0.05). The decrease was the greatest in the Mg plus vitamin B6 group, and was the least in the placebo group.

Conclusions

The findings indicated that Mg plus vitamin B6 and placebo has the greatest and the least effect on the mean score of PMS, respectively.

Topics

Related research

Menstrual Cycle › Premenstrual Disorders › Premenstrual Syndrome Treatment · General Gynecology › Clinical Practice › Pharmacology
Nahid Fathizadeh, Elham Ebrahimi, Mahboube Valiani, Naser Tavakoli, Manizhe Hojat Yar
N Fathizadeh, E Ebrahimi, M Valiani, N Tavakoli, M Yar
PMID 22069417 22069417 Fathizadeh et al. 2010, Fathizadeh 2010